Principal Investigator
Brain tumours are one of the leading causes of cancer related deaths. Glioblastoma (GBM) and Medulloblastoma are two high grade malignant brain tumours that differ strikingly in their clinical behaviour and underlying biology. they have been using high throughput genomic technologies to identify genetic alterations and delineate their role in pathogenesis of medulloblastomas. While the genetic alterations in GBMs are largely understood, their complexity accompanied by the intrinsic resistance and invasive potential of GBMs poses enormous challenge to identification of therapeutic targets in GBMs. They have been investigating the molecular basis of the intrinsic resistance of GBM cells to cell death.
Genome wide expression profiling studies including our own study has demonstrated that medulloblastoma is compri… more
We have carried out microRNA profiling of medulloblastomas in parallel with genome-wide expression profiling of… more
Glioblastoma (GBM) is the most common and highly aggressive primary malignant brain tumor. The intrinsic resista… more
"Medulloblastoma, a common pediatric malignant brain tumor consists of four molecular subgroups viz. WNT, SHH, G… more
Medulloblastoma is the most common and a highly malignant pediatric brain tumor located in the cerebellar region… more
Scientific Assistant
Scientific Assistant
Technician
Juniour Research Fellow
Juniour Research Fellow
Juniour Research Fellow
Juniour Research Fellow
Dasgupta A, Gupta T, Sridhar E, Shirsat N, Krishnatry R, Goda JS, Chinnaswamy G, Jalali R
Bharambe HS, Paul R, Panwalkar P, Jalali R, Sridhar E, Gupta T, Moiyadi A, Shetty P, Kazi S, Deogharkar A, Masurkar S, Yogi K, Kunder R, Gadewal N, Goel A, Goel N, Chinnaswamy G, Ramaswamy V, Shirsat NV
Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Goda JS, Jalali R
Joshi AA, Nerurkar AV, Shirsat NV